publication date: Dec. 21, 2010

In this issue: 

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

Also STAR trial can be completed with fewer women than planned, NSABP says.

NCCF, Ad Council plan public service ads on childhood cancer.

MSKCC hopes to raise $1 billion in five-year campaign.

Download (PDF 133KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.